Prolensa (Bausch & Lomb Incorporated)
Welcome to the PulseAid listing for the Prolensa drug offered from Bausch & Lomb Incorporated. This Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Bausch & Lomb Incorporated |
| NON-PROPRIETARY NAME: | Bromfenac Sodium |
| SUBSTANCE NAME: | BROMFENAC SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | SOLUTION/ DROPS |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-04-05 |
| END MARKETING DATE: | 0000-00-00 |
Prolensa HUMAN PRESCRIPTION DRUG Details:
| Item Description | Prolensa from Bausch & Lomb Incorporated |
| LABELER NAME: | Bausch & Lomb Incorporated |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.7(mg/mL) |
| START MARKETING DATE: | 2013-04-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 24208-602_7a5adc7f-537b-4b92-a008-206fa9c87700 |
| PRODUCT NDC: | 24208-602 |
| APPLICATION NUMBER: | NDA203168 |
Other BROMFENAC SODIUM Pharmaceutical Manufacturers / Labelers:
